A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older

Clinical trial NCT05566639 · COMPLETED

Trial details

NCT number: NCT05566639
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2022-09-14
Primary completion: 2024-01-05
Enrollment: 22502

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.